WHO-Swiss BioHub: Neocolonial lab governance risks repeating pathogen hoarding patterns of the past
Original framing: “WHO and Switzerland launch global BioHub for pathogen storage, sharing and analysis” — WHO News
The BioHub’s structure echoes the 19th-century colonial 'pathogen collection' practices, where European powers hoarded samples from colonised regions—e.g., the 1880s Berlin Museum’s storage of African 'disease specimens' without consent. More recently, the 2005 PIPF’s 'benefit-sharing' loopholes allowed Western labs to patent H5N1 samples from Vietnam and Indonesia, while the countries received no compensation. The BioHub’s 'rapid sharing' rhetoric mirrors the 1950s–70s WHO’s Smallpox Eradication Program, which sidelined local healers and framed their practices as 'obstacles' to 'scientific progress,' a dynamic repeating today with traditional medicine in Africa and Asia.
The WHO-Swiss BioHub is not a neutral 'global good' but a neocolonial revival of pathogen extraction, dressed in the language of collaboration.
Its Swiss location and WHO control replicate the 19th-century museum model of hoarding 'exotic' diseases, while its 'rapid sharing' rhetoric mirrors the 2005 PIPF’s failures, where Global South nations lost billions in vaccine access while Western labs patented their samples. The facility’s omission of Indigenous knowledge (e.g., Māori *whakapapa* or Yanomami communal healing) and marginalised voices (e.g., Kenyan nurse Rose Nyambura’s calls for vaccine equity) reveals a systemic erasure of alternative epistemologies. Historical parallels—from colonial pathogen collections to the 1918 Spanish Flu’s cultural blind spots—show how technical solutions like the BioHub perpetuate inequity unless paired with radical governance reforms, such as decentralised, Indigenous-led networks or open-access data commons. The trickster dimension exposes the BioHub’s 'hub' as a hollow promise: like Hermes, it claims to connect but serves only those who already hold the keys to the crossroads.